Abstract
Bifurcated electron transfer during ubiquinol oxidation is the key reaction of cytochrome bc1 complex catalysis. Binding of the competitive inhibitor 5-n-heptyl-6-hydroxy-4,7-dioxobenzothiazole to the Qo site of the cytochrome bc1 complex from Saccharomyces cerevisiae was analyzed by x-ray crystallography. This alkylhydroxydioxobenzothiazole is bound in its ionized form as evident from the crystal structure and confirmed by spectroscopic analysis, consistent with a measured pKa = 6.1 of the hydroxy group in detergent micelles. Stabilizing forces for the hydroxyquinone anion inhibitor include a polarized hydrogen bond to the iron-sulfur cluster ligand His181 and on-edge interactions via weak hydrogen bonds with cytochrome b residue Tyr279. The hydroxy group of the latter contributes to stabilization of the Rieske protein in the b-position by donating a hydrogen bond. The reported pH dependence of inhibition with lower efficacy at alkaline pH is attributed to the protonation state of His181 with a pKa of 7.5. Glu272, a proposed primary ligand and proton acceptor of ubiquinol, is not bound to the carbonyl group of the hydroxydioxobenzothiazole ring but is rotated out of the binding pocket toward the heme bL propionate A, to which it is hydrogen-bonded via a single water molecule. The observed hydrogen bonding pattern provides experimental evidence for the previously proposed proton exit pathway involving the heme propionate and a chain of water molecules. Binding of the alkyl-6-hydroxy-4,7-dioxobenzothiazole is discussed as resembling an intermediate step of ubiquinol oxidation, supporting a single occupancy model at the Qo site.
Highlights
Ubiquinol:cytochrome c oxidoreductase (cytochrome bc1 complex, EC 1.10.2.2) is a multisubunit membrane protein complex, which is one of the fundamental components of respiratory and photosynthetic electron transfer chains
The inhibitory efficacy of UHDBT was shown to depend on the oxidation-reduction poise of the catalytic subunits, demonstrated by enhanced binding when the Rieske protein is reduced [37]
The purified bc1 complex used in this study has a partially reduced Rieske and is fully inhibited by the applied amount of HHDBT
Summary
Protein Purification and Crystallization—The bc complex from the yeast S. cerevisiae was purified, and a co-complex with the antibody fragment Fv18E11 was formed and crystallized as previously described with the following minor modifications [6, 21]. The structure was refined using the coordinates of the stigmatellin-inhibited enzyme as a model (Protein Data Bank code 1KB9) after excluding all nonprotein molecules [7]. Water molecules were included according to peaks observed in the Fo Ϫ Fc electron density map contoured at 3 Their positions were refined yielding 326 molecules of which 203 are the same as in the original model (1KB9), and their numbering was kept. Lowering the pH by 0.5 units does not affect the structure of the catalytic subunits of the stigmatellin-inhibited enzyme, as judged by positional root mean square deviation (rmsd; Å) of superimposed atoms with LSQMAN yielding rmsdall/rmsdC␣ of 0.142/0.098, 0.175/0.118, and 0.204/0.133 for cytochrome b, cytochrome c1, and the Rieske protein, respectively (Dejavuu package; available on the World Wide Web at x-ray.bmc.uu.se/usf/). By-residue analysis of root mean square deviation in C␣ trace position and orientation was performed using the McLachlan algorithm as implemented in the program ProFit version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.